MG
FLGT icon

Michael Gelband’s Fulgent Genetics FLGT Stock Holding History

Michael Gelband’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-20,000
Closed -$1.04M – 2257
2020
Q4 		$1.04M Sell
20,000
-28,300
-59% -$1.18M 0.01% 838
2020
Q3 		$1.94M Buy
+48,300
New +$1.51M 0.04% 419

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Michael Gelband's FLGT Position: Q2 2026 in Review

Michael Gelband opened a new position in Fulgent Genetics (FLGT) in Q2 2026: 47,087 shares worth $966K. The stake represents 0.01% of the portfolio and ranks #1087 among its holdings. This is a return to the name: Michael Gelband previously reported a position in FLGT as recently as Q4 2025.

Michael Gelband first reported a position in FLGT in Q4 2019 and has held it in 16 quarters since. The position peaked at $2.62M in Q1 2023. 141 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Michael Gelband held 47,087 shares of Fulgent Genetics worth $966K as of Q2 2026.
  • Fulgent Genetics was a new Michael Gelband position in Q2 2026.
  • Fulgent Genetics made up 0.01% of Michael Gelband's portfolio in Q2 2026, its #1087 holding.
  • Michael Gelband first reported a position in Fulgent Genetics in Q4 2019 and has held it in 16 quarters since.
  • Michael Gelband's Fulgent Genetics position peaked at $2.62M in Q1 2023.
  • 141 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.